Evidence map›Paper›PMID 39293486›Full record

ArticleNature2024

A lymphocyte chemoaffinity axis for lung, non-intestinal mucosae and CNS.

Borja Ocón, Menglan Xiang, Yuhan Bi, Serena Tan, Kevin Brulois, Aiman Ayesha, Manali Kunte, Catherine Zhou, Melissa LaJevic, Nicole Lazarus and 11 more

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. GPR15-guided CD8Nature · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. CNS1-dependent regulatory T cells shape recovery from acute lung injury.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Borja Ocón *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. boconmor@stanford.edu.ORCID 0000-0002-5136-7844
Menglan Xiang *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mxiang1@stanford.edu.ORCID 0000-0003-4234-4998
Yuhan Bi *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. yub10@stanford.edu.ORCID 0000-0002-2123-0951
Serena TanDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Kevin BruloisDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Aiman AyeshaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0009-0002-7523-5974
Manali KuntePalo Alto Veterans Institute for Research, Palo Alto, CA, USA.
Catherine ZhouPalo Alto Veterans Institute for Research, Palo Alto, CA, USA.
Melissa LaJevicPalo Alto Veterans Institute for Research, Palo Alto, CA, USA.
Nicole LazarusPalo Alto Veterans Institute for Research, Palo Alto, CA, USA.
Francesca MengoniDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Tanya SharmaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Stephen MontgomeryDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-5200-3903
Jody E HooperDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-8209-3559
Mian HuangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Tracy HandelSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
John R D DawsonSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Irina KufarevaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Brian A ZabelPalo Alto Veterans Institute for Research, Palo Alto, CA, USA.
Junliang Pan *Palo Alto Veterans Institute for Research, Palo Alto, CA, USA.ORCID 0000-0002-2373-0917
Eugene C ButcherDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-8786-7907

Funding

Progenitor Cells for High Endothelium in the Immune ResponseR01AI130471 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI EUGENE C BUTCHER · 2017 to 2026
$5.0M
Intestinal Lymphocyte TraffickingR01AI047822 · NIAID · STANFORD UNIVERSITY · PI EUGENE C BUTCHER · 2001 to 2026
$4.7M
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12R01AI161880 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M, KUFAREVA, IRINA · 2021 to 2025
$3.4M
Identifying causal genetic variants and molecular mechanisms impacting mental healthR01MH125244 · NIMH · STANFORD UNIVERSITY · PI KUNDAJE, ANSHUL, MONTGOMERY, STEPHEN · 2021 to 2025
$3.0M
Novel Lymphocyte Chemoattractant Receptor and LigandR01AI178113 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI EUGENE C BUTCHER · 2024 to 2026
$2.1M
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2R01GM136202 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M, KUFAREVA, IRINA · 2020 to 2023
$1.9M
Spatiotemporally resolved architecture of G protein signaling downstream of CXCR4, the driver of lymphocyte migrationR21AI156662 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUFAREVA, IRINA · 2021 to 2022
$434k
Computationally informed discovery of scavenging-sparing inhibitors of CC chemokine receptor 2R21AI149369 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUFAREVA, IRINA · 2020 to 2021
$434k
New Approaches to Combat CNS Inflammation: Targeting a Metabolic Enzyme in Demyelinating DiseaseI01BX004115 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI BRIAN A. ZABEL · 2019 to 2026
–
BLRD VA I01 BX002919BLRD VA I01 BX004115NIAID NIH HHS R01 AI047822NIAID NIH HHS R01 AI130471NIAID NIH HHS R01 AI161880NIAID NIH HHS R01 AI178113NIAID NIH HHS R21 AI149369NIAID NIH HHS R21 AI156662NIGMS NIH HHS R01 GM136202NIMH NIH HHS R01 MH125244
6 · The paper itself

Abstract

Tissue-selective chemoattractants direct lymphocytes to epithelial surfaces to establish local immune environments, regulate immune responses to food antigens and commensal organisms, and protect from pathogens. Homeostatic chemoattractants for small intestines, colon and skin are known

Indexed as

Central Nervous SystemChemokines, CXCLungLymphocytesMucous MembraneReceptors, G-Protein-CoupledAnimalsAutoimmune DiseasesB-LymphocytesChemotaxisEpithelial CellsFemaleHumansImmune ToleranceImmunity, InnateImmunologic MemoryChemokines, CXCCXCL17 protein, humanGPR25 protein, humanReceptors, G-Protein-Coupled

Identifiers

PMID39293486
PMCPMC11887596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.